Japan, November 30, 2019: Fujitsu has announced the results of a joint research project it has been conducting with the…
NEW DELHI, NOVEMBER-07-2019: The US Food and Drug Administration (FDA) has approved Sandoz’ biosimilar Ziextenzo (pegfilgrastim-bmez). The biosimilar pegfilgrastim has been…